1. Home
  2. STVN vs FLR Comparison

STVN vs FLR Comparison

Compare STVN & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • FLR
  • Stock Information
  • Founded
  • STVN 1949
  • FLR 1912
  • Country
  • STVN Italy
  • FLR United States
  • Employees
  • STVN N/A
  • FLR N/A
  • Industry
  • STVN Containers/Packaging
  • FLR Military/Government/Technical
  • Sector
  • STVN Consumer Discretionary
  • FLR Industrials
  • Exchange
  • STVN Nasdaq
  • FLR Nasdaq
  • Market Cap
  • STVN 7.4B
  • FLR 7.2B
  • IPO Year
  • STVN 2021
  • FLR N/A
  • Fundamental
  • Price
  • STVN $23.98
  • FLR $43.03
  • Analyst Decision
  • STVN Buy
  • FLR Buy
  • Analyst Count
  • STVN 4
  • FLR 7
  • Target Price
  • STVN $25.13
  • FLR $50.57
  • AVG Volume (30 Days)
  • STVN 385.8K
  • FLR 3.3M
  • Earning Date
  • STVN 11-04-2025
  • FLR 11-07-2025
  • Dividend Yield
  • STVN 0.27%
  • FLR N/A
  • EPS Growth
  • STVN 6.78
  • FLR 970.51
  • EPS
  • STVN 0.57
  • FLR 24.07
  • Revenue
  • STVN $1,344,798,591.00
  • FLR $16,313,000,000.00
  • Revenue This Year
  • STVN $8.33
  • FLR $3.29
  • Revenue Next Year
  • STVN $10.12
  • FLR $4.33
  • P/E Ratio
  • STVN $41.34
  • FLR $1.78
  • Revenue Growth
  • STVN 5.28
  • FLR 3.61
  • 52 Week Low
  • STVN $17.12
  • FLR $29.20
  • 52 Week High
  • STVN $28.00
  • FLR $60.10
  • Technical
  • Relative Strength Index (RSI)
  • STVN 39.23
  • FLR 50.07
  • Support Level
  • STVN $24.81
  • FLR $42.53
  • Resistance Level
  • STVN $27.10
  • FLR $44.62
  • Average True Range (ATR)
  • STVN 1.33
  • FLR 1.54
  • MACD
  • STVN -0.35
  • FLR 0.21
  • Stochastic Oscillator
  • STVN 3.71
  • FLR 49.80

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

Share on Social Networks: